Literature DB >> 31951222

Corrigendum to: Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection.

Joseph J Carreno1, Iris M Tam2, Juliana L Meyers3, Elizabeth Esterberg3, Sean D Candrilli3, Thomas P Lodise1.   

Abstract

[This corrects the article DOI: 10.1093/ofid/ofz446.].
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Year:  2020        PMID： 31951222      PMCID： PMC6956781          DOI： 10.1093/ofid/ofz536

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


“Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection” by Joseph J Carreno et al (Open Forum Infect Dis. 2019. doi:10.1093/ofid/ofz446) This study was supported by Cipla. It was incorrect to list Achaogen, Inc., as the sponsor. The product Zemdri (Plazomicin) was acquired by Cipla. Cipla is considered the sponsor. The authors regret this oversight.
  6 in total

1.  Envisioning Future Urinary Tract Infection Diagnostics.

Authors:  Robin Patel; Christopher R Polage; Jennifer Dien Bard; Larissa May; Francesca M Lee; Valeria Fabre; Mary K Hayden; Sarah D B Doernberg; David A Haake; Barbara W Trautner; Larissa Grigoryan; Ephraim L Tsalik; Kimberly E Hanson
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 20.999

2.  Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018.

Authors:  Marya D Zilberberg; Brian H Nathanson; Kate Sulham; Andrew F Shorr
Journal:  Open Forum Infect Dis       Date:  2022-01-10       Impact factor: 3.835

3.  US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales.

Authors:  Thomas P Lodise; Anne Santerre Henriksen; Thomas Hadley; Nimish Patel
Journal:  Open Forum Infect Dis       Date:  2021-10-15       Impact factor: 3.835

4.  Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.

Authors:  Lewis F Neville; Itamar Shalit; Peter A Warn; Jacob T Rendell
Journal:  J Antimicrob Chemother       Date:  2022-05-29       Impact factor: 5.758

5.  Retrospective Cohort Study of the 12-Month Epidemiology, Treatment Patterns, Outcomes, and Health Care Costs Among Adult Patients With Complicated Urinary Tract Infections.

Authors:  Thomas P Lodise; Janna Manjelievskaia; Elizabeth Hoit Marchlewicz; Mauricio Rodriguez
Journal:  Open Forum Infect Dis       Date:  2022-06-20       Impact factor: 4.423

6.  Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States.

Authors:  Thomas P Lodise; Teena Chopra; Brian H Nathanson; Katherine Sulham; Mauricio Rodriguez
Journal:  Open Forum Infect Dis       Date:  2022-06-24       Impact factor: 4.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.